Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

BACKGROUND: Evidence suggests that both selective cyclooxygenase (COX)‐2 inhibitors and non‐selective non‐steroidal anti‐inflammatory drugs (NSAIDs) increase the risk of cardiovascular events. However, evidence from prospective studies of currently available COX‐2 inhibitors and non‐selective NSAIDs...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Farkouh, M E, Greenberg, J D, Jeger, R V, Ramanathan, K, Verheugt, F W A, Chesebro, J H, Kirshner, H, Hochman, J S, Lay, C L, Ruland, S, Mellein, B, Matchaba, P T, Fuster, V, Abramson, S B
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Group 2007
Fag:	Extended Report
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1954641/ https://ncbi.nlm.nih.gov/pubmed/17412741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.066001
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Lignende værker